SCOPINARO, NICOLA
 Distribuzione geografica
Continente #
EU - Europa 32.758
AS - Asia 3.433
NA - Nord America 2.205
SA - Sud America 271
AF - Africa 40
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 38.715
Nazione #
IT - Italia 32.240
US - Stati Uniti d'America 2.029
SG - Singapore 1.564
CN - Cina 895
VN - Vietnam 453
FR - Francia 293
BD - Bangladesh 215
BR - Brasile 171
HK - Hong Kong 104
FI - Finlandia 65
CA - Canada 60
JP - Giappone 42
DE - Germania 39
AR - Argentina 34
MX - Messico 30
GB - Regno Unito 24
IQ - Iraq 23
CH - Svizzera 20
IN - India 20
ID - Indonesia 18
EC - Ecuador 17
JM - Giamaica 17
PK - Pakistan 14
CL - Cile 13
IE - Irlanda 13
NL - Olanda 12
PH - Filippine 12
CR - Costa Rica 11
CO - Colombia 10
HN - Honduras 10
RU - Federazione Russa 10
TH - Thailandia 10
VE - Venezuela 10
NI - Nicaragua 9
ES - Italia 8
PR - Porto Rico 8
JO - Giordania 7
MA - Marocco 7
ZA - Sudafrica 7
BB - Barbados 6
LB - Libano 6
AU - Australia 5
DZ - Algeria 5
PE - Perù 5
PL - Polonia 5
PY - Paraguay 5
SV - El Salvador 5
NP - Nepal 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
UA - Ucraina 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
KZ - Kazakistan 3
PA - Panama 3
RO - Romania 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TR - Turchia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GP - Guadalupe 2
GT - Guatemala 2
KR - Corea 2
LV - Lettonia 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
VI - Stati Uniti Isole Vergini 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
GD - Grenada 1
GF - Guiana Francese 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
Totale 38.703
Città #
Genova 19.791
Genoa 7.037
Rapallo 3.284
Vado Ligure 1.886
Singapore 787
San Jose 639
Lauterbourg 278
Ashburn 210
Beijing 136
Ho Chi Minh City 135
New York 125
Hanoi 104
Hong Kong 99
Helsinki 65
Santa Clara 57
Los Angeles 43
Bordighera 39
Tokyo 37
Frankfurt am Main 33
Chicago 29
Dallas 21
Zurich 20
Rome 19
Da Nang 18
Haiphong 18
Milan 17
Tianjin 17
Mexico City 16
Atlanta 14
Dublin 14
Philadelphia 13
Phoenix 13
Toronto 12
Des Moines 11
Kingston 11
Houston 10
Montreal 10
Naples 10
Orem 10
Queens 10
São Paulo 10
Amsterdam 9
Buffalo 9
Florence 9
Las Vegas 9
Managua 9
San Francisco 9
Washington 9
Baghdad 8
City of London 8
Hải Dương 8
San José 8
Turin 8
Biên Hòa 7
Bologna 7
Kansas City 7
Amman 6
Boston 6
Bridgetown 6
Brooklyn 6
Can Tho 6
Charlotte 6
Chennai 6
Cincinnati 6
Dhaka 6
Shanghai 6
Changsha 5
Denver 5
Lahore 5
Louisville 5
Memphis 5
Miami 5
New Delhi 5
Palermo 5
Pasadena 5
Salem 5
Santiago 5
Sydney 5
Tampa 5
Alexandria 4
Belo Horizonte 4
Bogotá 4
Brescia 4
Council Bluffs 4
Dearborn 4
Detroit 4
Greenville 4
Guayaquil 4
Jinan 4
Manchester 4
Newark 4
Ninh Bình 4
Oran 4
Quito 4
Rio de Janeiro 4
San Pedro Sula 4
St Louis 4
Tashkent 4
Tegucigalpa 4
The Bronx 4
Totale 35.441
Nome #
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 231
A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS) 228
LA RESEZIONE GASTRICA CON GASTROENTEROANASTOMOSI SECONDO ROUX PER LA TERAPIA CHIRURGICA DELL'ULCERA GASTRICA E DUODENALE. 225
Biliopancreatic diversion for obesity: state of the art. 221
Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. 218
Biliopancreatic diversion 218
Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion 216
Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage 215
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 215
Effect of biliopancreatic diversion on hypertension in severely obese patients. 211
A comparison of a personal series of biliopancreatic diversion and literaturedata on gastric bypass help to explain the mechanisms of resolution of type 2diabetes by the two operations. 208
Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. 201
Alexithymia and eating behaviour in severely obese patients. 199
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 199
Bariatric surgery in adolescents: a long-term follow-up study 199
Biliopancreatic diversion for obesity at eighteen years 197
Physical Activity After Surgically Obtained Weight Loss: Study with a SenseWear Armband in Subjects Undergoing Biliopancreatic Diversion 196
Beta-cell function improvement after biliopancreatic diversion in subjects withtype 2 diabetes and morbid obesity. 194
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 194
10 YEARS EXPERIENCE WITH BILIOPANCREATIC DIVERSION (BPD) 191
The long-term impact of biliopancreatic diversion on glycemic control in the severely obese with type 2 diabetes mellitus in relation to preoperative duration of diabetes. 190
BILIO-PANCREATIC BYPASS FOR OBESITY: II. INITIAL EXPERIENCE IN MAN. 189
Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss. 182
Three-factor Eating Questionnaire and Eating Disorder Inventory in the evaluation of psychological traits and emotional reactivity in obese patients 180
Type 2 diabetes and weight loss following biliopancreatic diversion for obesity. 179
Interdisciplinary European guidelines on metabolic and bariatric surgery. 179
Biliopancreatic diversion reduces QT interval and dispersion in severely obese patients. 173
[A case of severe obesity treated jejunoileal bypass. 1-year clinical course]. 172
Colorectal cancer after biliopancreatic diversion for obesity 171
[Role of carbohydrates in the diet of gout patients]. 171
Role of preoperative Multitest findings on predicting postoperative infectiouscomplications. 169
Does Biliopancreatic Diversion Carry Increased Risk for Colorectal Cancer? A Cohort Study 168
A new approach to the fashioning of the gastroenteroanastomosis in laparoscopicstandard biliopancreatic diversion. 167
Effects of Gastric Bypass on Type 2. Diabetes in Patients with BMI 30 to 35 167
'Simple' form of Caroli's disease 164
CLINICAL USE OF PARTIAL BILIOPANCREATIC BYPASS FOR OBESITY. DETAILS OF OPERATIVE TECHNIQUE AND FOLLOW-UP MANAGEMENT. 164
[Aspects ofneurohypophysial function in the course of hyperthyroidism]. 162
[Behavior of plasma insulin and GIP in obese patients subjected tobiliopancreatic bypass]. 161
Three factor eating questionnaire and eating disorder inventory in the evaluation of psychological traits and emotional reactivity in obese persons 160
The Effects of Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients with Mild Obesity (BMI 30-35 kg/m2) and Simple Overweight (BMI 25-30 kg/m 2) A Prospective Controlled Study. 160
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion 160
Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 160
Leptin and HDL-cholesterol in non-diabetic normotensive subjects. 159
Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. 157
[Action of parathormone on the urinary excretion of mono- and bivalent cations in man]. 157
Are BPD subjects at increase risk of colon cancer? 157
Gastric cancer and Roux-en-Y gastric bypass. 156
Sub-clinical organ damage in hypertension and obesity 156
Quality of life in obese subjects following biliopancreatic diversion. 155
[Behavior of serum proteins and lipids after jejuno-ileal bypass for obesity]. 154
. A late complication of Hickman right atrial catheter 153
WERNICKE-KORSAKOFF ENCEPHALOPATHY FOLLOWING BILIOPANCREATIC DIVERSION 153
Energy and nitrogen absorption after biliopancreatic diversion 152
Serum levels of osteopontin predict diabetes remission after bariatric surgery 152
Serum leptin concentration in obese patients with binge eating disorder. 151
Biliopancreatic Diversion. 151
Preoperative resting energy expenditure does not predict weight loss and maintenance after vertical banded gastroplasty. 150
BILIOPANCREATIC DIVERSION 150
Interdisciplinary European guidelines for surgery for severe (morbid) obesity. 150
[Automated determination of total nitrogen in urine and feces]. 150
Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. 149
Orally-administered Serum Ranitidine Concentration after BiliopancreaticDiversion for Obesity. 149
Insulin-like growth factor-I in human malnutrition: relationship with some body composition and nutritional parameters. 148
[Behavior of urinary excretion of monoand bi-valent cations after intravenous overload of calcium]. 148
Radiology of patients with vertical banded gastroplasty. 148
Intraluminal penetration of the band in patients with adjustable silicone gastricbanding: radiological findings. 147
Short-term liver function after biliopancreatic diversion. 147
Relationships of serum leptin to clinical and anthropometric findings in obese patients. 145
BEHAVIORAL APPROACH TO PROMOTE EATING HABITS AND LIFESTYLE CHANGES FOLLOWING GASTRIC CHANGES FOR OBESITY 145
INTRALUMINAL PENETRATION OF THE BAND IN PATIENTS WITH ADJUSTABLE SILICONE GASTRIC BAMDING: REDIOLOGICAL FINDINGS 145
Bariatric surgery in adolescents: A very long-term follow-up survey after biliopancreatic diversion (BPD) 145
Pregnancies in an 18-year follow-up after biliopancreatic diversion 144
Binge eating in massively obese patients undergoing bariatric surgery. 144
Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. 144
Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35kg/m2: an integrative review of early studies. 143
Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity 143
Resting Energy Expenditure in long-term postobese subjects after weight normalization by dieting or biliopancreatic diversion 142
Night eating in obesity: a descriptive study. 142
Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. 142
[Urinary excretion of oxalate after bilio-pancreatic bypass for obesity]. 141
Biliopancreatic diversion. 140
Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion. 140
[Behavior of plasma enteroglucagon and neurotensin in obese patients subjected tobiliopancreatic bypass]. 139
[Behavior of plasma pancreatic polypeptides and motilin in obese patientssubjected to biliopancreatic bypass]. 139
liver morphology and function after biliopancreatic bypass 139
Intravenous nutritional support in pregnancy. Experience followingbiliopancreatic diversion. 139
[A case of atrophic gastritis with achlorhydria and hypergastrinemia functionallyregressed after ileo-jejunal bypass for obesity]. 138
Body composition and energy expenditure in obese patients prior to and following biliopancreatic diversion for obesity. 138
Editors' comment: bariatrics and diabetes meta-analysis. 138
[Behavior of the serum electrolytes after jejuno-ileal bypass for obesity]. 137
Why the Operation I Prefer is Biliopancreatic Diversion (BPD). 137
[2 cases of death caused by hepatic insufficiency after jejuno-ileal bypass forobesity]. 137
Can a protocol for glycaemic control improve type 2 diabetes outcomes aftergastric bypass? 137
Interdisciplinary European Guidelines on metabolic and bariatric surgery 137
Eating Disorder Inventory in the assessment of psychosocial status in the obese patients prior to and at long term following biliopancreatic diversion for obesity 137
[Development of the partial biliopancreatic bypass for obesity]. 136
BONE HISTOMORPHOMETRY AND VITAMIN D STATUS AFTER BILIOPANCREATIC BYPASS FOR OBESITY. 135
[Gastric resection with Roux gastroenteroanastomosis in the surgical treatment of gastric and duodenal ulcer]. 135
[Protein absorption after bilio-pancreatic bypass for obesity]. 135
Biliopancreatic diversion innonobese patients with type 2 diabetes: impact and mechanisms 134
Totale 16.335
Categoria #
all - tutte 119.052
article - articoli 115.532
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.520
Totale 238.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.753 66 358 226 525 162 204 295 814 132 373 96 502
2022/20233.930 420 178 27 432 628 784 8 380 655 22 335 61
2023/20241.592 103 227 18 185 114 346 38 82 83 48 117 231
2024/20254.605 101 383 174 263 661 482 442 707 182 227 396 587
2025/20268.110 936 181 508 727 936 893 1.430 309 544 773 518 355
2026/2027687 687 0 0 0 0 0 0 0 0 0 0 0
Totale 38.782